NRT smoking cessation aids in Canada received a boost in 2020 as smoking rates in the country declined in the wake of the COVID-19 pandemic, which increased consumer concerns about respiratory health and general wellbeing. As these fears begin to recede in 2021, current value growth is expected to be more muted, perhaps as Canadians willing to consider giving up smoking have already done so. An estimated 1 in 10 Canadians smoked cigarettes regularly in 2020, with 11% aged 25 and older being a cu...

Euromonitor International’s NRT Smoking Cessation Aids in Canada report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.

Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.


Why buy this report?
* Get a detailed picture of the NRT Smoking Cessation Aids market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years’ experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.